Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hu, CT
Boxun Hu, Storrs, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090101516 | METHODS AND APPARATUS FOR THE SYNTHESIS OF USEFUL COMPOUNDS - The present invention relates to methods and apparatus for activation of a low reactivity, non-polar chemical compound. In one example embodiment, the method comprises introducing the low reactivity chemical compound to a catalyst. At least one of (a) an oxidizing agent or a reducing agent and (b) a polar compound is provided to the catalyst and the chemical compound. An alternating current is applied to the catalyst to produce an activation reaction in the chemical compound. This activation reaction produces a useful product. The present invention also relates to a method for oxidizing aromatic compounds by electrocatalysis to oxidized products. | 04-23-2009 |
| 20090134037 | Methods and apparatus for the synthesis of useful compounds - The present invention relates to methods and apparatus for activation of a low reactivity, non-polar chemical compound. In one example embodiment, the method comprises introducing the low reactivity chemical compound to a catalyst. At least one of (a) an oxidizing agent or a reducing agent and (b) a polar compound is provided to the catalyst and the chemical compound. An alternating current is applied to the catalyst to produce an activation reaction in the chemical compound. This activation reaction produces a useful product. | 05-28-2009 |
Chunlong Hu, Stamford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100108744 | CLOSED LOOP WIRE BONDING METHODS AND BONDING FORCE CALIBRATION - A method of applying bonding energy to form a bond between a portion of a wire and a contact of a bonding location using a wire bonding machine is provided. The method includes: (1) moving a bonding tool towards the contact; (2) detecting when a portion of the contact ( | 05-06-2010 |
Lain-Yen Hu, Niantic, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090192202 | ANDROGEN MODULATORS - The present invention is directed to a new class of 4-cyano-phenoxy-alkyl carboxyl derivatives and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth. | 07-30-2009 |
Larry Hu, Redding, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20120036072 | Transport Logistics Systems and Methods - A logistics system manages the shipments of goods supplied from a plurality of different shippers by a plurality of carriers. It has a variety of modules integrated with each other to perform various functionalities. For example, it may have a purchasing module evaluating proposals by shippers for respective shipments of goods and awarding contracts for the shipments to the plurality of carriers. It may have an optimization module analyzing the proposals and informing the purchasing module if an opportunity exists for at least some of the shipments to be consolidated, in which case at least one contract awarded by the purchasing module is for a consolidated group of the shipments. It may have a contract administration module maintaining information relating to the status of proposals received and contracts awarded by the purchasing module. It may have a scheduling module scheduling shipments according to the awarded contracts. It may also have a shipment management module tracking the status of shipments awarded by the purchasing module and scheduled by said scheduling module. It may further have a financial module authorizing payments according to the status of shipments tracked by the shipment management module are passed between first and second asynchronous clock domains. | 02-09-2012 |
Po Hu, Norwalk, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100161379 | METHODS AND SYSTEMS FOR PREDICTING CONSUMER BEHAVIOR FROM TRANSACTION CARD PURCHASES - A computer-based method for predicting consumer behavior is provided. The method is performed using a computer system coupled to a database. The method includes recording consumer data in the database for each consumer of a global population of consumers including historical purchases made by each consumer using a transaction card, defining a life event by assigning spending variables to the life event, determining a sample group of consumers that are experiencing the life event based on the consumer data stored within the database with respect to the spending variables, generating a predictive model based on historical purchases made by consumers within the sample group, and applying the predictive model to predict each consumer within the global population that will experience the life event. The predictive model is applied using the computer system. A list of consumers predicted to experience the life event within a predetermined time period is output. | 06-24-2010 |
Shanghui Hu, East Lyme, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110118476 | Process for Preparing Chiral Compounds - The present invention is directed to a 2-deoxyribose-5-phosphate aldolase (DERA) chemoenzymatic process for making chiral compounds. | 05-19-2011 |
Shaojing Hu, Hamden, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090082392 | Substituted Carboxylic Acids - The present invention relates to compounds and pharmaceutically acceptable salts of formula (I): | 03-26-2009 |
Shuanghua Hu, Milford, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110207749 | Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase - The present disclosure is generally directed to compounds that can inhibit DAGLα and/or β activity, compositions comprising such compounds, and methods for inhibiting DAGLα and/or β activity. | 08-25-2011 |
| 20110207772 | Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase - The present disclosure is generally directed to compounds that can inhibit DAGLα and/or β activity, compositions comprising such compounds, and methods for inhibiting DAGLα and/or β activity. | 08-25-2011 |
Wangyang Hu, Burlington, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100293000 | SYSTEM FOR EVALUATING POTENTIAL CLAIM OUTCOMES USING RELATED HISTORICAL DATA - A computer system includes a data storage device. The data storage module receives, stores, and provides access to historical claim data. A categorical aggregation component comprising program instructions stored in a program memory provides categorized and aggregated historical claim data by identifying claim categories based on the historical claim data, each of the one or more claim categories associated with a respective set of claim characteristics, identifying claims of the historical claim data associated with one of the claim categories, assigning each identified claim to one of a plurality of total severity ranges based on the total severity of the identified claim, and determining an average cost per claim year for claims of each total severity range when executed by a computer processor. | 11-18-2010 |
Welqlan Hu, Manchester, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110187199 | APPARATUS AND METHOD FOR BOOSTING OUTPUT OF A GENERATOR SET - An apparatus and method for boosting output of a generator set are provided. The output of the generator set is connected to an electrical load. The apparatus includes an energy storage unit, and a power-electronic unit. The energy storage unit uses batteries and capacitors to store electric energy. The power-electronic unit measures an electrical parameter of the output of the generator set. Based on the measured electrical parameter and a predefined criterion, the power-electronic unit determines additional energy required by the electrical load. Thereafter, the power-electronic unit supplies the additional energy to the electrical load. The additional energy is drawn from the energy storage unit. | 08-04-2011 |
Yuntao Thomas Hu, Orange, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090312223 | Method of Controlling Structure and Rheology of Low Active Liquid Cleansers by Selecting Perfume Components - The invention relates to method of enhancing viscosity of low active liquid cleanser by adding perfumes individual perfume components or mixtures of components. | 12-17-2009 |
| 20090312224 | Method of Reducing Viscosity of Concentrated Liquid Cleansers by Selection of Perfume Components - The invention relates to method of reducing viscosity of high active liquid concentrate cleanser by adding perfumes, individual perfume components, or mixtures of components. | 12-17-2009 |
| 20100009891 | Liquid cleansing compositions comprising microfibrous cellulose suspending polymers - The present invention relates to personal care liquid cleansing compositions comprising bacterially produced microfibrous cellulose (MFC) suspending polymers which have not previously been used in personal care compositions. | 01-14-2010 |
Zhigang Hu, Ridgefield, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090089602 | METHOD AND SYSTEM OF PEAK POWER ENFORCEMENT VIA AUTONOMOUS TOKEN-BASED CONTROL AND MANAGEMENT - A method of power management of a system of connected components includes initializing a token allocation map across the connected components, wherein each component is assigned a power budget as determined by a number of allocated tokens in the token allocation map, monitoring utilization sensor inputs and command state vector inputs, determining, at first periodic time intervals, a current performance level, a current power consumption level and an assigned power budget for the system based on the utilization sensor inputs and the command state vector inputs, and determining, at second periodic time intervals, a token re-allocation map based on the current performance level, the current power consumption level and the assigned power budget for the system, according to a re-assigned power budget of at least one of the connected components, while enforcing a power consumption limit based on a total number of allocated tokens in the system. | 04-02-2009 |
Zhiwei Hu, New Haven, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110117114 | Neovascular-Targeted Immunoconjugates - Immunoconjugates for treating diseases associated with neovascularization such as cancer, rheumatoid arthritis, the exudative form of macular degeneration, and atherosclerosis are described. The immunoconjugates typically consist of the Fc region of a human IgG1 immunoglobulin including the hinge, or other effector domain or domains that can elicit, when administered to a patient, a cytolytic immune response or cytotoxic effect against a targeted cell. The effector domain is conjugated to a targeting domain which comprises a factor VII mutant that binds with high affinity and specificity to tissue factor but does not initiate blood clotting such as factor VII having a substitution of alanine for lysine-341 or of alanine for serine-344. | 05-19-2011 |
Zhiwei Hu, Cheshire, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20080206227 | FACTOR VII CONJUGATES FOR SELECTIVELY TREATING NEOVASCULARIZATION DISORDERS - Methods and compositions are provided for the treatment of diseases such as exudative macular degeneration, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, retinal neovascularization, iris neovascularization, corneal neovascularization, ocular tumors, and other disorders of the eye, cancer, and inflammatory disorders. The method involves administering a conjugate, referred to as fVIIPD, containing a photosensitizer and a targeting molecule such as factor VII (“fVII”), fVIIa, or modified fVII, which binds with high affinity and specificity to tissue factor (TF). TF is more highly expressed, abnormally expressed or specifically expressed on endothelial cells lining the luminal surface of pathological neovasculature, than on normal vasculature, thus providing a specific and accessible therapeutic target. Following administration of fVIIPD, the compound specifically binds to the pathological neovasculature of the eye by interaction of the targeting molecule with TF expressed by endothelial cells within abnormal blood vessels. The photosensitizer may then be activated with a non-thermal laser light for selective destruction of abnormal vasculature. | 08-28-2008 |